Proteasome-dependent degradation of p27/kip1 in gliomas

Journal of Neuropathology and Experimental Neurology

Volumn 58, Issue 7, 1999, Pages 691-696

  Piva, Roberto ^a   Cancelli, Iacopo ^a   Cavalla, Paola ^a   Bortolotto, Simona ^a   Dominguez, Jorge ^b   Draetta, Giulio F ^b   Schiffer, Davide ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Anaplasia; Cell cycle; Gliomas; P27 kip1; Proteasome degradation; Ubiquitin

Indexed keywords

CYCLIN A; CYCLIN D; CYCLIN E; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN P27;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CELL CYCLE; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALIGNANT TRANSFORMATION; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

EID: 0032796455     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199907000-00002     Document Type: Article

References (33)

1. Hochstrasser M. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 1995;7:215-23
2. King RW. How proteolysis drives cell cycle. Science 1996;274: 1652-59
3. Di Cunto F, Topley G, Calautti E, et al. Inhibitory function of p21/ Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control. Science 1998;280:1069-72
4. Pahl HL, Bauerle PA. Control of gene expression by proteolysis. Curr Opin Cell Biol 1996;8:340-47
5. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994;79:13-21
6. Restifo NP, Esquivel F, Kawakami Y, et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-72
7. Spataro V, Toda D, Craig R, et al. Resistance to diverse drugs and to ultraviolet light conferred by overexpression of a novel human 26S proteasome subunit. J Biol Chem 1997;272:30470-75
8. Soos TJ, Kiyokawa H, Yan JS, et al. Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ 1996;7:135-46
9. Pagano M, Tam SW, Theodoras AM, et al. Role of the ubiquitinproteasome pathway in regulating abundance of the cyclin-dependent inhibitor p27. Science 1995;269:682-85
10. Hengst L, Reed SI. Translational control of p27Kipl accumulation during the cell cycle. Science 1996;271:1861-64
11. Fredersdorf S, Burns J, Milne AM, et al. High level expression of p27kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997;94:6380-85
12. Kawamata N, Morosetti R, Miller CW, et al. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kipl in human malignancies. Cancer Res 1995;55:2266-69
13. Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP. p27/kip1 mutation found in breast cancer. Cancer Res 1996;56:2400-404
14. Ponce-Castaneda MV, Lee MH, Latres E, et al. p27Kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 1995;55:1211-14
15. Catzavelos C, Bhattacharya N, Ung YC, et al. Decreased levels of the cell cycle inhibitor p27kip1 protein Prognostic implications in primary breast cancer. Nature Med 1997;3:227-30
16. Loda M, Cukor B, Tam SW, et al. Increased proteasome-dependent degradation of cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med 1997;3:231-34
17. Mori M, Mimori K, Shirashi T, et al. p27 expression and gastric carcinoma. Nature Med 1997;3:593
18. Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med 1997;3:222-25
19. Tan P, Cady B, Wanner M, et al. The cell cycle inhibitor p27 is an independent prognostic marker in small (Tlab) invasive breast carcinomas. Cancer Res 1997;57:1259-63
20. Esposito V, Baldi A, De Luca A, et al. Prognostic role of the cyclindependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 1997;57:3381-85
21. Tsihlias J, Kapusta LR, DeBoer G, et al. Loss of cyclin-dependent kinase inhibitor p27/kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 1998;58:542-48
22. Singh SP, Lipman J, Goldman H, et al. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Res 1998;58:1730-35
23. Piva R, Cavalla P, Bortolotto S, Cordera S, Richiardi P, Schiffer D. p27/kip1 expression in astrocytic gliomas. Neurosci Lett 1997;234: 127-30
24. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system. In: World Health Organization International Histological Classification of Tumours. Berlin: Springer-Verlag, 1993:13-16
25. Lämmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
26. Tong W, Kiyokawa H, Soos TJ, et al. The absence of p27Kip1, an inhibitor of G1 cyclin-dependent kinases, uncouples differentiation and growth arrest during the granulosa-luted transition. Cell Growth Differ 1998;9:787-94
27. Durand B, Gao FB, Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/kip1 and timing of oligodendrocyte differentiation. EMBO J 1997;16:306-17
28. Zabludoff SD, Csete M, Wagner R, Yu X, Wold BJ. p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis. Cell Growth Differ 1998;9:1-11
29. Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. EMBO J 1997;16:5334-44
30. Pause A, Lee S, Worrel RA, et al. The von Hippel-Lindau tumor suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. Proc Natl Acad Sci USA 1997;94:2156-61
31. Pause A, Lee S, Lonergan KM, Klausner R. The von Hippel-Lindau tumor suppressor gene is required for cell-cycle exit upon serum withdrawal. Proc Natl Acad Sci USA 1998;95:993-98
32. Orend G, Hunter T, Ruoslahti E. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kipl in anchorage-independent cells. Oncogene 1998;16:2575-83
33. Li DM, Sun H. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 1988;95:15406-11